Skip to main content
. 2022 Jul 20;9:868635. doi: 10.3389/fcvm.2022.868635

Figure 2.

Figure 2

Vectorious Medical Technologies V-LAP™ wireless sensor, a second-generation heart failure (HF) monitoring system, used for remote LAP-guided Therapy Optimization during COVID-19 era at a patient with HF. (A) The unexpanded biosensor before implantation; (B) The biosensor after ex vivo expansion; (C) The catheter with the biosensor during deployment; (D) The 3D echocardiographic check of the biosensor positioning, as part of the interatrial septum (detail image) between the right atrium and left atrium (above); (E) The external unit (the belt for the patient) continuously captures and records the left atrial pressure; (F) The continuous diagram recording of the mean left arterial pressure monitored with V-LAP™. Alerts of the mean arterial pressure overpassing the normal values are transmitted via mobile to the cardiologist, allowing her/him to take action by optimizing the therapy. Reproduced from Di Mario et al. (58), with the courtesy of the authors.